Frankfurt - Delayed Quote • EUR
Luye Pharma Group Ltd. (LUP.F)
As of 8:03 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,739,076.0000
1,653,796.0000
182,371.0000
1,033,449.0000
Investing Cash Flow
-2,056,103.0000
-1,658,308.0000
-3,436,032.0000
138,197.0000
Financing Cash Flow
1,531,436.0000
54,148.0000
1,878,897.0000
253,981.0000
End Cash Position
4,587,235.0000
2,323,740.0000
2,438,252.0000
3,865,385.0000
Capital Expenditure
-3,223,039.0000
-1,163,659.0000
-1,541,595.0000
-1,519,883.0000
Issuance of Capital Stock
1,112,121.0000
189,156.0000
1,044,477.0000
--
Issuance of Debt
9,828,640.0000
7,656,204.0000
7,155,047.0000
7,352,854.0000
Repayment of Debt
-9,584,253.0000
-8,301,897.0000
-7,536,692.0000
-5,896,686.0000
Repurchase of Capital Stock
--
--
--
-77,962.0000
Free Cash Flow
575,417.0000
490,137.0000
-1,359,224.0000
-486,434.0000
12/31/2020 - 8/14/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade